DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 180 filers reported holding DIPLOMAT PHARMACY INC in Q3 2018. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $150,000 | -44.0% | 11,174 | -18.5% | 0.01% | -33.3% |
| Q3 2018 | $268,000 | -22.8% | 13,717 | +1.2% | 0.01% | -30.8% |
| Q2 2018 | $347,000 | +27.1% | 13,560 | -1.0% | 0.01% | +18.2% |
| Q1 2018 | $273,000 | +1.5% | 13,701 | +2.0% | 0.01% | 0.0% |
| Q4 2017 | $269,000 | +7.6% | 13,430 | +11.5% | 0.01% | 0.0% |
| Q3 2017 | $250,000 | +36.6% | 12,050 | -2.4% | 0.01% | +37.5% |
| Q2 2017 | $183,000 | – | 12,348 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |